Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1951 1
1973 1
2007 1
2013 1
2016 1
2017 5
2018 6
2019 8
2020 6
2021 10
2022 3
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis.
Lebwohl MG, Stein Gold L, Strober B, Papp KA, Armstrong AW, Bagel J, Kircik L, Ehst B, Hong HC, Soung J, Fromowitz J, Guenthner S, Piscitelli SC, Rubenstein DS, Brown PM, Tallman AM, Bissonnette R. Lebwohl MG, et al. Among authors: tallman am. N Engl J Med. 2021 Dec 9;385(24):2219-2229. doi: 10.1056/NEJMoa2103629. N Engl J Med. 2021. PMID: 34879448 Clinical Trial.
Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical review.
Silverberg JI, Boguniewicz M, Quintana FJ, Clark RA, Gross L, Hirano I, Tallman AM, Brown PM, Fredericks D, Rubenstein DS, McHale KA. Silverberg JI, et al. Among authors: tallman am. J Allergy Clin Immunol. 2023 Dec 27:S0091-6749(23)02547-2. doi: 10.1016/j.jaci.2023.12.013. Online ahead of print. J Allergy Clin Immunol. 2023. PMID: 38154665 Free article. Review.
One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial.
Strober B, Stein Gold L, Bissonnette R, Armstrong AW, Kircik L, Tyring SK, Piscitelli SC, Brown PM, Rubenstein DS, Tallman AM, Lebwohl MG. Strober B, et al. Among authors: tallman am. J Am Acad Dermatol. 2022 Oct;87(4):800-806. doi: 10.1016/j.jaad.2022.06.1171. Epub 2022 Jun 27. J Am Acad Dermatol. 2022. PMID: 35772599 Free article.
Burden of atopic dermatitis in Asia.
Tsai TF, Rajagopalan M, Chu CY, Encarnacion L, Gerber RA, Santos-Estrella P, Llamado LJQ, Tallman AM. Tsai TF, et al. Among authors: tallman am. J Dermatol. 2019 Oct;46(10):825-834. doi: 10.1111/1346-8138.15048. Epub 2019 Aug 22. J Dermatol. 2019. PMID: 31436343 Review.
Tolerability of Topical Treatments for Atopic Dermatitis.
Draelos ZD, Feldman SR, Berman B, Olivadoti M, Sierka D, Tallman AM, Zielinski MA, Ports WC, Baldwin S. Draelos ZD, et al. Among authors: tallman am. Dermatol Ther (Heidelb). 2019 Mar;9(1):71-102. doi: 10.1007/s13555-019-0280-7. Epub 2019 Jan 24. Dermatol Ther (Heidelb). 2019. PMID: 30680551 Free PMC article. Review.
Topical Agents for the Treatment of Atopic Dermatitis.
Eichenfield LF, Luger T, Papp K, Silverberg JI, Sierka D, Zang C, Tallman AM, Zielinski MA, Ports WC. Eichenfield LF, et al. Among authors: tallman am. J Drugs Dermatol. 2020 Jan 1;19(1):50-64. doi: 10.36849/JDD.2020.4508. J Drugs Dermatol. 2020. PMID: 31985912 Review.
Understanding the Burden of Atopic Dermatitis in Africa and the Middle East.
Al-Afif KAM, Buraik MA, Buddenkotte J, Mounir M, Gerber R, Ahmed HM, Tallman AM, Steinhoff M. Al-Afif KAM, et al. Among authors: tallman am. Dermatol Ther (Heidelb). 2019 Jun;9(2):223-241. doi: 10.1007/s13555-019-0285-2. Epub 2019 Mar 8. Dermatol Ther (Heidelb). 2019. PMID: 30850961 Free PMC article. Review.
47 results